Our Research & Technology division partners with innovator companies in pharmaceuticals API’s, intermediates areas to develop innovative, cost effective and safe processes for NCEs, generic molecules as well as provide life cycle management for existing molecules for global clients.
We have an impeccable track record of delivering active pharmaceutical ingredients (APIs), active ingredients (AIs) and intermediates to global clients with outmost confidentiality. Our facilities are built to meet the specific needs of clients and stringent requirements of the United States, European, and Japanese markets.
Our comprehensive environment, health and safety (EHS) policy ensures that the interests of all constituents are safeguarded. Processes are developed at our factory with significant focus on process understanding with a view to increasing yield and throughput as also on optimization of effluent treatability processes. Strong mechanistic understanding and use of process simulation tools render scaleup facile and efficient. We try to imbibe the 12 principles of Green Chemistry during the process development. Additionally, we also focus on waste treatability as part of our development projects and ensure that it is a part of the lab report before scaleup.